
"The research has suggested there is a window of opportunity just prior to, during, and immediately after surgical removal of primary cancer when anti-cancer interventions could reduce the risk of development of disseminated stage-four metastatic cancer later in the lifespan of the patient," the hospital said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cBkuPaf
via
IFTTT
0 comments:
Post a Comment